Embryotoxic and Teratogenic Effects of Norfloxacin in Pregnant Female Albino Rats

Figure 2

Cross-section through the spinal cord and thoracic vertebrae of fetuses at 20th day of gestation, showing absence of ossification in treated group (T) (2000 mg norfloxacin/Kg⋅b⋅wt from 6th to 15th day of pregnancy) in comparison with normal ossification in control group (C) (×10 H & E).

(a)

(b)